Aequs SEZ Approves ₹650 Cr Promoter Warrant Infusion

Aequs SEZ Ltd.

has approved a proposed equity infusion of ₹650 crore through the issuance of warrants to the promoter group, providing fresh capital to support the company’s planned business expansion. Under the proposed structure, 50% of the warrant issue price will be payable upfront, with the remaining amount payable as per the applicable terms at the time of conversion into equity shares. The fund infusion is expected to strengthen Aequs’ balance sheet and provide financial resources for capacity expansion across its aerospace and consumer businesses. The company has been expanding its manufacturing footprint and capabilities in aerospace components, precision engineering and consumer-oriented products, and the additional capital could support investments in new capacity, manufacturing infrastructure and related growth initiatives. The proposed promoter participation also indicates continued financial commitment from the promoter group toward the company’s expansion plans. The infusion is particularly relevant as the aerospace manufacturing ecosystem in India is witnessing increasing interest in localisation, supply-chain diversification and higher-value manufacturing. For Aequs, additional equity capital can provide funding flexibility while reducing reliance on debt for expansion-related expenditure. The impact on the company’s financial profile will ultimately depend on the deployment of funds, the timing of capacity additions and the pace at which the new facilities contribute to revenue and profitability. Overall, the proposed ₹650 crore warrant issue is aimed at funding Aequs’ growth plans, particularly in aerospace and consumer manufacturing capacity, while providing the company with additional capital to execute its expansion strategy.